Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsInvestigators evaluated dasatinib-based two-step induction with the primary endpoint of three-year event-free survival as treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
[Blood Advances]
Home Newsletters Hematopoiesis News Dasatinib-Based Two-Step Induction for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
